Two groups of patients who requested extradural analgesia were studied in a withinpatient controlled trial and received either 0.5% bupivacaine with adrenaline 5 (J-g/ml or 0.5% bupivacaine plain as the analgesic agent (first group) or 0.5% bupivacaine or 2% lignocaine both with adrenaline 5 (Ag/ml (second group). Arterial pressure, central venous pressure (CVP), maternal and foetal heart rate and uterine contractions were monitored continuously. There was no significant difference in any of the cardiovascular measurements when solutions of 0.5% bupivacaine (with or without adrenaline 5 fig/ml) were used. The second group had a statistically significant increase in CVP during the study period in which 2% lignocaine was used. The position of the patient did not affect the cardiovascular measurements in either group. Since the addition of adrenaline 5 [xg/ml to bupivacaine solutions did not confer any apparent advantages, it is concluded that plain solutions of 0.5% bupivacaine should be used except in the longest labours.
In'a previous study, Broadfield and his colleagues (1975) showed that there was a reduction in central venous pressure (CVP) and an increase in maternal heart rate (MHR) when plain 0.5% bupivacaine (Marcain) was used to provide continuous extradural analgesia in labour. These changes in CVP and MHR were not seen when either 0.25% or 0.5% bupivacaine with adrenaline 2.5 (xg/ml was used. However, the changes were small and, because the drugs were administered in a random fashion to a small group of patients only, it was not possible to determine the effects of the addition of adrenaline in any individual patient. The present study was undertaken to provide data on the effects of the addition of adrenaline to 0.5% bupivacaine in patients who acted as their own controls (first series).
In earlier studies of the cardiovascular responses to extradural analgesia, lignocaine was used as the local anaesthetic agent (Bonica, Berges and Morikawa, 1970; Lees, Scott and Kerr, 1970; Bonica et al., 1971; Bonicaet al., 1972; Stanton-Hicks, Berges and Bonica, 1973) . Therefore we have studied another series of patients who received lignocaine 2% with adrenaline 5 (ig/ml, and 0.5% bupivacaine with adrenaline 5 (J.g/ml. As in the first series, each patient acted as her own control.
PATIENTS
Eight parturient women, in the Obstetric Unit at King's College Hospital, with no evidence of cardiovascular or respiratory disease were studied. All had requested extradural analgesia and had given written informed consent for the additional monitoring involved in this study. The study had been approved by the Ethics Sub-committee, King's College Hospital.
METHODS
The methods of measurement have been described in detail elsewhere (Broadfield et al., 1975) . In order to measure CVP, a 70-cm, 14-gauge Intramedicut was inserted, under local analgesia, into the basilic vein at the antecubital fossa. The catheter was connected to a Bell and Howell L221 transducer and the catheter tip positioned with reference to the pressure wave-form. The signal was then damped electrically to minimize the effects of respiration. The radial artery was cannulated percutaneously, also under local analgesia, with an 18-gauge Medicut. This was attached to a Bell and Howell L221 transducer, and both the arterial and venous lines were flushed with heparinized saline (10 mg heparin in 500 ml saline) by means of two CFS Intraflo pumps (Sorenson Research Co. Ltd).
Foetal heart rate (FHR) was monitored using a foetal scalp electrode attached to a Hewlett Packard 8021A Cardiotocograph. Uterine contractions were measured using an intra-uterine catheter connected to a Bell and Howell L221 pressure transducer. The outputs from the three Bell and Howell transducers and the cardiotocograph were fed into a Devices M8 pen-recorder. The following measurements were monitored before and for 45 min after the initial and each supplementary dose of local analgesic solution: maternal central venous pressure (CVP), systolic (SAP), mean (MAP) and diastolic (DAP) arterial pressure; maternal heart rate (MHR), foetal heart (FHR) and uterine contractions.
In the two series of patients the drug administered for the first dose of local analgesic solution was selected randomly, and thereafter each patient received alternate doses of either 0.5% bupivacaine plain, or 0.5% bupivacaine with adrenaline 5 ng/ml (first series); in the second series, either 0.5% bupivacaine or 2% lignocaine, both with adrenaline 5 [xg/ml, was given.
On average 8 ml of 0.5% bupivacaine or 2% lignocaine was used as the initial dose. Over any 4-hr period a dose of bupivacaine 2 mg/kg was not exceeded. Lignocaine was administered so that less than 200 mg was administered at any one time. Supplementary doses of the analgesic solution were administered by the attending anaesthetist as required, so that no patient developed pain between analgesic supplements.
The results were analysed as follows: the mean readings for CVP, MHR, systolic and diastolic arterial pressures were calculated 1 min before control value, at time zero, and 1 min after. For the subsequent readings, at intervals of 5 min for 45 min, the measurements were derived from the average of three values: that at the stated time together with the value 1 min before and 1 min after that time. Statistical analysis was carried out using the Student t test for paired data.
Obstetric procedures
All the patients had an artificial rupture of the membranes and intravenous prostaglandin stimulation of labour. These procedures were performed by the attending obstetrician.
Extradural analgesia
With the patient in the left lateral position, a Portex cannula was inserted to the extradural space through a Tuohy needle which was then withdrawn; the cannula was fixed to the patient's back by waterproof strapping, and the distal end, to which a Millipore filter (Millex 0.22) was attached, was brought over the right shoulder. A 2-ml test dose of bupivacaine was given, and, if no adverse cardiovascular effects occurred, the test solution was administered.
For this study the patients were allowed to lie in the position they found most comfortable, although normally in the Obstetric Unit patients having extradural analgesia are nursed in the lateral position. CVP. Figure 1 represents the overall mean values for the two solutions plotted against time. It can be seen that when using plain 0.5% bupivacaine CVP varied little during the 45-min study period (table I) . MHR. Figure 2 shows mean MHR plotted against time, and table II the individual mean values and SD. Although MHR was faster throughout the study period when plain 0.5% bupivacaine was used, this difference never achieved statistical significance except at time zero.
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Maternal arterial pressure. Figure 3 shows the mean value for systolic (S), mean (M) and diastolic (D) arterial pressure plotted against time and tables III Mean arterial pressure was derived from the diastolic and IV show the individual mean values and SD. pressure plus one-third of the pulse pressure. It can and SD. It can be seen that in the patients receiving 2% lignocaine with adrenaline 5 [xg/ml, the CVP increased over the study period. This increase was statistically significant (P< 0.05) at 25,35 and 45 min.
MHR. Figure 5 shows the mean value plotted against time, and table VI the individual mean values with SD. There was no statistically significant difference in MHR between the two solutions.
Maternal arterial pressure. 
Analysis of initial injection
Analysis of the cardiovascular changes following the first injection have been compared with those changes occurring after subsequent injections. This was necessary since before the initial injection there was no sympathetic block and it is possible that cardiovascular changes occurring in response to the initial dose of drug were masked subsequently by the established sympathetic block. There were, however, no statistically significant differences in the cardiovascular measurements made after the first injection as compared with subsequent injections in either series of patients.
Patient position
Scrutiny of the continuous traces in patients in both series did not show any significant changes which could be related to patient position.
DISCUSSION
The cardiovascular effects of extradural blockade are determined by the extent of the sympathetic block, the actions of adrenaline, if present, the direct cardiovascular effects of local analgesic agents, and the circulatory condition of the patient (Bromage, 1967; Kennedy et al., 1969; Bonica, Berges and Morikawa, 1970) .
When using plain solutions of 0.5% bupicavaine any cardiovascular changes will be mainly the result of sympathetic block causing dilatation of resistance and capacitance vessels in the area of analgesia. Concurrently there will be a compensatory vasoconstriction in unanaesthetized areas because of normal homeostatic mechanisms (Ward, Bonica and Freund, 1965; Shimosato and Etsten, 1969) . Broadfield and his colleagues (1975) concluded that as a decrease in CVP and an increase in MHR occurred in their study in association with the use of plain 0.5% bupivacaine the addition of adrenaline 5 |Jig/ml to solutions of 0.5% bupivacaine might have beneficial effects, but they suggested that a withinpatient-controlled study was necessary. In the present study, although there were variations in CVP, MHR, SAP, MAP and DAP, none of these changes was statistically significant.
Pain cannot have been a factor in these changes as patients were given supplementary doses of analgesic solution at appropriate intervals. Scott and Kerr (1963) , Lees and others (1967) , and Scott (1968) have shown that inferior caval occlusion is the rule rather than the exception in patients in the supine position in late pregnancy, and that the development of the caval occlusion syndrome depends on the adequacy of the venous return to the heart via the collateral circulation. It is, of course, normal practice in our Obstetric Unit for patients to be nursed in the lateral position. However, in the present study the patients were being monitored closely, and they were permitted to adopt the position which was the most comfortable. It is of interest that the continuous'traces do not show any cardiovascular or FHR changes which could relate to patient position. However, in our previous study (Broadfield et al., 1975) two patients out of 13 developed the "caval occlusion syndrome" whilst supine, and therefore we advocate that patients in labour, especially those having extradural analgesia, should be nursed in the lateral position, even when cardiovascular monitoring facilities are available.
The cardiovascular effects of adrenaline when added to solutions in the extradural space have been studied by Bonica and his colleagues (1971) . Low concentrations of adrenaline stimulate (3 -receptors in the heart and arterial walls (Green and Kepchar, 1959; Goodman and Gillman, 1970 ) and a-receptors in the veins (Green and Kepchar, 1959; Wood, 1965) . However, in vessels in which the sympathetic innervation has been interrupted surgically, the P-effects of adrenaline are enhanced (Stein, Harpuder and Byer, 1949) . As a sympathetic block always accompanies extradural analgesia the total venous response is the result of a balance between a-and p-effects.
The (3-effects of adrenaline on the heart and arterial vessels would be expected to cause an increase in HR and SAP, a reduction in DAP, and a small decrease in MAP. Although small changes in arterial pressure and MHR did occur in this study, when 0.5% bupivacaine with adrenaline 5 fxg/ml was used, these changes were not statistically significant when compared with those occurring in association with plain 0.5% bupivacaine. By contrast, the marked changes, ascribed to adrenaline, reported by Bonica and his colleagues (1971) when adrenaline 5 [xg/ml was added to 2% lignocaine in the extradural space may be explained by the fact that they were using large volumes of lignocaine (20 ml) with a resulting high extradural block, and that their subjects were nonpregnant volunteers.
In the second series of patients in which 2% lignocaine and 0.5% bupivacaine, both with adrenaline 5 (ig/ml, were used the only statistically significant cardiovascular change was the increase in CVP associated with lignocaine. This could be a result of the direct myocardial depressant action of lignocaine affecting stroke volume, since there were no significant changes in MHR, or of the central stimulatory actions of lignocaine (McWhirter et al., 1973) .
We conclude from our studies that the addition of adrenaline 5 y-g/ml to solutions of 0.5% bupivacaine does not significantly alter maternal CVP, heart rate or arterial pressure. Reynolds and Taylor (1971) have shown that the addition of adrenaline 5 fxg/ml to 0.5% bupivacaine neither significantly prolongs its analgesic action nor significantly affects maternal or foetal plasma bupivacaine concentrations except when large doses are given (Reynolds, Hargrove and Wyman, 1973) . In addition, adrenaline may cause anterior spinal artery thrombosis and may inhibit the force of uterine contractions (Gunther and Bauman, 1969) although it may not delay cervical dilatation in the presence of oxytocic stimulation (Craft, Epstein and Cookley, 1972) . For these reasons, where 0.5% bupivacaine is the chosen agent for the provision of continuous extradural analgesia in labour, it is suggested that the solution without adrenaline be used for all but the longest labours. Se estudiaron dos grupos de pacientes que solicitaron analgesia extradural en una prueba controlada en el propio paciente, y que recibieron bien bupivacaina al 0,5% con adrenalina 5 ng/ml o bupivacaina al 0,5% simple como agente analgesico (primer grupo), o bupivacaina al 0,5% o lignocaina al 2%, ambas con adrenalina 5 ng/ml (el segundo grupo). La presion arterial, la presion venosa central (CVP), el ritmo cardiaco fetal y maternal, y las concentraciones uterinas se vigilaron continuamente. No hubo diferencia significativa en ninguna de las mediciones cardiovasculares cuando se usaron soluciones de bupivacaina al 0,5% (con o sin adrenalina 5 jig/ml). En los pacientes del segundo grupo hubo un aumento estadisticamente significativo en CVP durante el periodo de estudio en que se utilizo la lignocaina al 2%. La position del paciente no afecto las mediciones cardiovasculares en ninguno de los dos grupos. Al no ofrecer ninguna ventaja, la adicion de adrenalina 5 ng/ml a las soluciones de bupivacaina, se llega a la conclusion de que se deberian usar soluciones simples de bupivacaina al 0,5% excepto en los partos mas largos.
